ORGANIC Farma Zdrowia S.A. (WSE:ORG)
Poland · Delayed Price · Currency is PLN 10.40
0.00 (0.00%)
At close: Sep 23, 2026
ORGANIC Farma Zdrowia Ratios and Metrics
Market cap in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 57 | 74 | 58 | 28 | 11 | 22 | |
Market Cap Growth | 23.81% | 28.57% | 110.00% | 151.26% | -50.00% | -26.47% |
Enterprise Value | 68 | 83 | 65 | 37 | 25 | 29 |
Last Close Price | 10.40 | 13.50 | 10.50 | 5.00 | 1.99 | 3.98 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 51.74 | 52.80 | 35.83 | 3.70 | - | - |
PS Ratio | 0.41 | 0.55 | 0.48 | 0.25 | 0.11 | 0.22 |
PB Ratio | 8.33 | 12.23 | 12.37 | 9.00 | -3.46 | 2.66 |
P/TBV Ratio | 17.84 | 37.31 | 36.64 | 25.48 | - | 3.71 |
P/FCF Ratio | - | - | 107.59 | - | - | - |
P/OCF Ratio | 335.93 | 49.79 | 21.17 | 134.91 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.48 | 0.62 | 0.54 | 0.34 | 0.24 | 0.29 |
EV/EBITDA Ratio | 13.79 | 17.07 | 14.73 | 17.05 | - | - |
EV/EBIT Ratio | 24.10 | 28.07 | 22.99 | 74.88 | - | - |
EV/FCF Ratio | - | - | 121.23 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.96 | 1.59 | 1.68 | 2.84 | -5.10 | 2.08 |
Debt / EBITDA Ratio | 2.72 | 2.00 | 1.78 | 4.01 | - | - |
Debt / FCF Ratio | - | - | 14.65 | - | - | - |
Net Debt / Equity Ratio | 1.64 | 1.18 | 1.17 | 1.81 | -3.58 | -0.20 |
Net Debt / EBITDA Ratio | 2.27 | 1.48 | 1.23 | 2.55 | -5.73 | 0.23 |
Net Debt / FCF Ratio | -5.69 | -9.04 | 10.15 | -20.31 | -2.49 | 0.28 |
Asset Turnover | 4.49 | 4.14 | 4.05 | 3.42 | 2.47 | 2.09 |
Inventory Turnover | 8.17 | 7.71 | 8.70 | 8.07 | 7.60 | 7.15 |
Quick Ratio | 0.52 | 0.48 | 0.57 | 0.50 | 0.34 | 0.78 |
Current Ratio | 1.12 | 1.04 | 1.08 | 0.93 | 0.61 | 1.09 |
Return on Equity (ROE) | 17.50% | 26.18% | 41.73% | - | -42.52% | -186.44% |
Return on Assets (ROA) | 5.64% | 5.67% | 5.92% | 0.96% | -6.06% | -13.64% |
Return on Invested Capital (ROIC) | 12.10% | 19.21% | 23.18% | 12.20% | -148.66% | -67.96% |
Return on Capital Employed (ROCE) | 23.00% | 26.20% | 26.00% | 5.00% | 340.70% | -60.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.93% | 1.89% | 2.79% | 27.01% | -9.84% | -62.32% |
FCF Yield | -3.46% | -1.07% | 0.93% | -0.99% | -41.59% | -26.15% |
Buyback Yield / Dilution | - | - | - | - | - | -12.69% |